Cargando…
Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
BACKGROUND: Observational data suggest that the fixed initial recommended tacrolimus (Tc) dosing (0.2 mg/kg/day) results in supratherapeutic drug levels in some patients during the early posttransplant period. The aim of the study was to analyze a wide panel of patient-related factors and their inte...
Autores principales: | Krzyżowska, Kinga, Kolonko, Aureliusz, Giza, Piotr, Chudek, Jerzy, Więcek, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831822/ https://www.ncbi.nlm.nih.gov/pubmed/29651435 http://dx.doi.org/10.1155/2018/4573452 |
Ejemplares similares
-
Number of Regularly Prescribed Drugs and Intrapatient Tacrolimus Trough Levels Variability in Stable Kidney Transplant Recipients
por: Giza, Piotr, et al.
Publicado: (2020) -
The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation
por: Kolonko, Aureliusz, et al.
Publicado: (2021) -
The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2018) -
The Association of Long-Functioning Hemodialysis Vascular Access with Prevalence of Left Ventricular Hypertrophy in Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2014) -
Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic
por: Kolonko, Aureliusz, et al.
Publicado: (2021)